Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$62.36
*  
2.05
3.18%
Get TEVA Alerts
*Delayed - data as of Apr. 27, 2015 12:44 ET  -  Find a broker to begin trading TEVA now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    TEVA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By













TEVA Acquisition Of Mylan Would Produce Generic Powerhouse
4/25/2015 9:23:00 AM - Seeking Alpha




French biotech's B-vitamin beats placebo in Phase 3 MS study
4/24/2015 12:57:00 PM - Seeking Alpha






What Are the Conditions of the Mylan-Teva Deal?
4/23/2015 7:01:00 PM - Market Realist


The Teva-Mylan Combination: What’s the Rationale?
4/23/2015 7:00:00 PM - Market Realist




Mylan Chooses Its Own Adventure
4/23/2015 3:27:00 PM - Seeking Alpha




The Mylan–Teva Deal: Arbitrage Spread Analysis
4/22/2015 7:33:00 PM - Market Realist


Teva Pharmaceuticals Makes a Hostile Bid for Mylan
4/22/2015 7:33:00 PM - Market Realist


Teva Guides for Lower Revenues in 2015
4/22/2015 6:21:00 PM - Market Realist




Will Teva Manage To Complete The Takeover Of Mylan?
4/22/2015 5:44:00 PM - Seeking Alpha


Don't Cash In On Perrigo Yet, Upside Still Possible
4/22/2015 5:27:00 PM - Seeking Alpha